Bellicum Announces Presentations on Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association

May 17, 2018 by Website Admin in

Bellicum announced that two abstracts on its lead product candidate BPX-501 have been selected for presentation at the 23rd Congress of the European Hematology Association.

Tweet

Share

Pin it

Previous StoryMoleculin to Begin Clinical Trials at UMC Southwest Cancer Center Next StoryMoleculin Invited to Present to International BioForum 2018 Conference